Thirty Years of Polyamine-Related Approaches to Cancer Therapy. Retrospect and Prospect. Part 2. Structural Analogues and Derivatives
Journal:
Current Drug Targets
Volume:
4
Page:
565-585
Author(s):
Nikolaus Seiler
Melanocortins and their Receptors and Antagonists
Journal:
Current Drug Targets
Volume:
4
Page:
586-597
Author(s):
Voisey J., Carroll L. and van Daal A.
COX-2 and Colorectal Cancer
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
2229-2251
Author(s):
A. Ferrandez, S. Prescott and R. W. Burt
Overview: Translating Hsp90 Biology into Hsp90 Drugs
Journal:
Current Cancer Drug Targets
Volume:
3
Page:
297-300
Author(s):
Paul Workman
Genes and Proteins Governing the Cellular Sensitivity to HSP90 Inhibitors: A Mechanistic Perspective
Journal:
Current Cancer Drug Targets
Volume:
3
Page:
331-341
Author(s):
Alison Maloney, Paul A. Clarke and Paul Workman
The Clinical Applications of Heat Shock Protein Inhibitors in Cancer - Present and Future
Journal:
Current Cancer Drug Targets
Volume:
3
Page:
385-390
Author(s):
Udai Banerji, Ian Judson and Paul Workman
The Design, Synthesis and Application of Stereochemical and Directional Peptide Isomers: A Critical Review
Journal:
Current Protein & Peptide Science
Volume:
4
Page:
339-356
Author(s):
P. M. Fischer
Cytotoxic T Cell Reponses Against Immunoglobulin in Malignant and Normal B Cells: Implications for Tumor Immunity and Autoimmunity
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
1889-1903
Author(s):
Clair S. Gricks and John G. Gribben
Gene Therapy of Cancer with Interleukin-12
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
1981-1991
Author(s):
Guillermo Mazzolini, Jesus Prieto and Ignacio Melero
Immune Response Manipulation: Recombinant Immunoreceptors Endow T-Cells with Predefined Specificity
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
1992-2001
Author(s):
Hinrich Abken, Andreas Hombach and Claudia Heuser